Johnson & Johnson (NYSE:JNJ)

JNJ - Johnson & Johnson Johnson & Johnson is one of the leading healthcare companies in the world, with over one billion people using its products daily. The company has a well-diversified global footprint with the US accounting for 50% of the company’s revenues, and international markets constituting the remaining 50%.

The company offers the world’s largest range of consumer healthcare products and a comprehensive portfolio of surgical technology and specialty solutions. It is a global leader in seven consumer categories and owns a strong portfolio of iconic brands.

Some of its top selling and well-known brands include Neutrogena, Aveeno, Listerine, Tylenol, Motrin, and Zyrtec. Johnson & Johnson operates through an extensive distribution network, product portfolio, and a huge customer base. It is one of the most reputed healthcare organizations in the world and has developed a deep understanding of its customers’ needs with more than a century’s old experience.

Key Investment Data

  • Ticker: nyse:jnj
  • Sector: Healthcare
  • Industry: Drug Manufacturers - General
  • Market Cap: 441.86B
  • Market Cap Group: Mega Cap
  • P/E: 17.61
  • Dividend Yield: 2.53%

Competitors

The competitive landscape is important as they compete for the same business. Below is the list of competitors in the same industry. While not displayed, a number of metrics you can also use to evaluate your picks are the Chowder Score, the Relative Strength Index (RSI), the Graham Number, and the Piotroski F-Score.

Ticker Ticker Company Market Cap P/E Aristocrat Graph SectorID IndustryID
JNJ NYSE:JNJ Johnson & Johnson 441.86 17.61 YES 1 8 35
PFE NYSE:PFE Pfizer Inc. 308.43 14.61 NO 1 8 35
ABBV NYSE:ABBV AbbVie Inc 240.20 11.06 YES 1 8 35
LLY NYSE:LLY Lilly 233.52 28.96 NO 1 8 35
MRK NYSE:MRK Merck & Co., Inc. 205.56 14.08 NO 1 8 35
BMY NYSE:BMY Bristol Myers Squibb Co. 144.12 9.11 NO 1 8 35
AMGN NASDAQ:AMGN Amgen Inc. 132.57 14.21 NO 1 8 35
GILD NASDAQ:GILD Gilead Sciences Inc. 90.03 8.16 NO 1 8 35

Top Picks by Bay Street Experts

Expert stock analysts have shared their opinions, and sometimes prediction, on the company.

For more top picks from stock analysts on Bay Street, check the full list of top picks by expect stock analysts from investment and asset management firms.

Not all analysts are equal and they don't cover the same type of stocks. The analysts performance and ownership is tracked for comparison.

Johnson & Johnson - FAQ

What is the stock ticker for Johnson & Johnson?

The stock ticker for Johnson & Johnson is NYSE:JNJ.

Is Johnson & Johnson a good stock to buy?

You need to consider your investment strategy and how NYSE:JNJ can fit in your portfolio.

The current dividend income score of 7/10 and dividend growth score of 6/10. Those 2 metrics together should help you decide the fit for your portfolio. Be it for income or for growth.

Is Johnson & Johnson a Buy, Sell or Hold?

The Dividend Snapshot Opportunity Score of 67 out of 100.

The score reflects the strength of a buy signal but it does not show a sell signal if it's low. The higher the better.

A sell signal is more difficult as it often relies on the reason you bought the stock in the first place.


Beat the TSX
With a Winning Investment Strategy

My portfolio is generating over 12% annual returns since 2009. It's not from the beginning of the year or from 2019, it's from 2009 !!! That's a consistent return which means using the rule of 72, I double my portfolio every 6 years.

My approach is simple but you need key data that I have cultivated with the Dividend Snapshot Screeners. No other investment services provide you with easy to understand data but also actionable data. No hidden magic.

In fact, I have tried all of the investment services for dividend investors like a crash test dummy of investment services. Just ask me, and you'll learn why there was nothing I could use out there and that's how the Dividend Snapshot Screeners were borned!

DISCLOSURE: Please note that I may have a position in one or many of the holdings listed. For a complete list of my holdings, please see my Dividend Portfolio.

DISCLAIMER: Please note that this blog post represents my opinion and not an advice/recommendation. I am not a financial adviser, I am not qualified to give financial advice. Before you buy any stocks/funds consult with a qualified financial planner. Make your investment decisions at your own risk – see my full disclaimer for more details.